ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025
An international survey of recalcitrant and recurrent tinea of the glabrous skin-A potential indicator of antifungal resistance.
Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Deep and disseminated dermatophytosis in immunocompromised populations-A systematic review.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Pooled it
- Article
- Clinical description and management of two terbinafine-resistant cases of tinea caused bySkin health and disease · 2026Article
- Review
- A Chinese warning: Terbinafine-resistant Trichophyton indotineae, a global dermatological challenge.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Article
- Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Review
- Superficial fungal infections in children in Northern Finland between 2000 and 2021: a single-center study.Microbiology spectrum · 2025Article
- An international survey of recalcitrant and recurrent tinea of the glabrous skin-A potential indicator of antifungal resistance.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Article
- Recalcitrant and recurrent tinea: Lessons from an international survey.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025Article
- The American Academy of Dermatology and International League of Dermatological Societies' Drug Resistant Dermatophytes (Tinea) Registry: The latest addition to the COVID-19, mpox, and Emerging Infections Registry.JAAD international · 2025Article
- Dermatophyte Treatment Failure: A Rapid Global Response to an Emerging Global Health Issue.Acta dermato-venereologica · 2025Article
- Artificial Intelligence and Large Language Models in the Fight Against Superficial Fungal Infections: Friend or Foe?Clinical, cosmetic and investigational dermatology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere has been a global rise in cases of dermatophytosis and, in particular, recalcitrant and recurrent cases on tinea of the glabrous skin. This phenomenon, particularly prevalent in India, has been linked to the concerning rise of antifungal resistance. The challenge is amplified by a dearth of comprehensive, international data to understand the global scope and characteristics of such cases.
objectivesThis study aims to collate international insights, focusing on areas outside Europe (as this was previously published), to map the extent and characteristics of clinical and, where possible, laboratory confirmed tinea of the glabrous skin through an online survey administered to dermatologists globally.
methodsAn online survey was distributed from February 2022 to July 2023 and captured data on respondents' experience of recalcitrant and recurrent tinea of the glabrous skin over the preceding 3 years.
resultsA total of 260 responses were received spreads across 36 countries, excluding Europe. In total, 91.7% reported seeing cases of recalcitrant or recurrent tinea of the glabrous skin over the preceding 3 years. Common anatomical sites affected were the trunk and groin. T. mentagrophytes and T. rubrum were the predominant species implicated, and there were low rates of laboratory confirmed dermatophyte resistance.
conclusionsThe high rates of reported recalcitrant and recurrent tinea of the glabrous skin underscore an urgent need for global collaborative efforts and enhanced diagnostic measures. The findings advocate for the establishment of a standardized global disease registry, regulation of over-the-counter antifungal and steroid combinations, correlation of clinical suspicion with laboratory confirmed drug resistance and exploration of alternative therapeutic strategies to mitigate the burgeoning challenge of dermatophyte resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.